Mucormycosis – resurgence of a deadly opportunist during COVID-19 pandemic: Four case reports

Table 1 Summary of cases of mucormycosis associated with coronavirus disease 2019

Ref.	Country	Age (yr)/sex	Site	Comorbidities	Outcome
Mehta et al[11]	India	60/Male	Rhino-orbito-cerebral mucormycosis	Uncontrolled diabetes	Death
Werthman et al[12]	United States	33/Female	Rhino-orbito-cerebral mucormycosis	Diabetes, asthma, hypertension	Death
Hanley et al[13]	United Kingdom	22/Male	Disseminated (involving the hilar lymph nodes, heart, brain, and kidney)/NA	Pancreatitis	Death
Placik et al[14]	Arizona	49/ Male	Pulmonary mucormycosis	None	Death
Monte et al[15]	Brazil	86/Male	Gastrointestinal mucormycosis	Hypertension	Death
Mekonnen et al[16]	United States	60/Male	Rhino-orbital mucormycosis	Diabetes, asthma, hypertension, hyperlipidaemia	Death
Pasero et al[17]	Italy	66/Male	Sinopulmonary mucormycosis	Lymphopenia, Hypertension	Death
This case	India	4 males, 49 ± 10 (39–57)	Oral mucormycosis	Diabetes mellitus	3 alive, one lost to follow up